Status:
NOT_YET_RECRUITING
the Impact of Transcutaneous Vagus Nerve Stimulation on Cardiovascular Events in Patients With Acute Myocardial Infarction
Lead Sponsor:
Shanghai East Hospital
Conditions:
Acute Myocardial Infarction (AMI)
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The acute mortality rate of acute myocardial infarction (AMI) reduced significantly due to emergency reperfusion and subsequent treatment strategies. However, it remains a major cause of disability an...
Eligibility Criteria
Inclusion
- \*\*Inclusion Criteria\*\*
- Age between 18 and 80 years old (including 18 and 80 years old).
- Patients with acute myocardial infarction who have undergone revascularization of the culprit vessel within 24 hours of onset.
- Willing to participate in this study and have signed the informed consent form.
- \*\*Exclusion Criteria\*\*
- Hemodynamically unstable, with cardiogenic shock, requiring medication to maintain blood pressure and heart rate.
- Baseline systolic blood pressure \<90 mmHg or diastolic blood pressure \<40 mmHg.
- Average heart rate under monitoring \<50 beats per minute.
- Patients with II or III degree atrioventricular (AV) block or sick sinus syndrome who have not had a permanent pacemaker implanted.
- Baseline (before the use of antiarrhythmic drugs) QTc interval ≥500 ms, PR interval \>280 ms.
- Patients who are participating in other clinical studies.
- Other reasons deemed by the investigator as unsuitable for participation in this study.
Exclusion
Key Trial Info
Start Date :
June 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2028
Estimated Enrollment :
278 Patients enrolled
Trial Details
Trial ID
NCT06991283
Start Date
June 1 2025
End Date
October 1 2028
Last Update
May 27 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.